Associations of diabetes mellitus and other cardiovascular disease risk factors with decline in the ankle–brachial index

We compared the associations of diabetes mellitus (DM) and other cardiovascular disease (CVD) risk factors with decline in the ankle–brachial index (ABI) over 4 years in participants with and without peripheral artery disease (PAD). A total of 566 participants, 300 with PAD, were followed prospectively for 4 years. Mean (SD) baseline ABI values were 0.70 (0.13) for participants with both PAD and DM, 0.67 (0.14) for participants with only PAD, 1.10 (0.13) for participants with only DM, and 1.10 (0.10) for participants with neither PAD nor DM. After adjusting for age, sex, and baseline ABI, the corresponding ABI change from baseline to 4-year follow-up were −0.02, –0.04, +0.05, and +0.05, respectively. Compared to participants with neither PAD nor DM, participants with only PAD showed significantly more ABI decline (p <0.01), while the decline in participants with both PAD and DM was borderline non-significant (p = 0.06). After adjustments for baseline ABI, age, sex, African American ethnicity, and other CVD risk factors, independent factors associated with ABI decline in participants with PAD in the lower ABI leg were older age and elevated D-dimer. DM was not related to ABI decline. Despite being an important risk factor for PAD, DM was not independently associated with ABI decline. This could reflect the effect of DM promoting both PAD and lower-extremity arterial stiffness, resulting in a small decline in the ABI over time. In conclusion, ABI change over time in persons with diabetes may not accurately reflect underlying atherosclerosis.

[1]  V. Aboyans,et al.  Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. , 2009, Journal of vascular surgery.

[2]  L. Ferrucci,et al.  Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). , 2009, Journal of the American College of Cardiology.

[3]  A. P. L. Mota,et al.  Hypercoagulability Markers in Patients With Peripheral Arterial Disease: Association to Ankle-brachial Index , 2009, Angiology.

[4]  L. Ferrucci,et al.  Lower Extremity Ischemia, Calf Skeletal Muscle Characteristics, and Functional Impairment in Peripheral Arterial Disease , 2007, Journal of the American Geriatrics Society.

[5]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  L. Ferrucci,et al.  Lower extremity nerve function in patients with lower extremity ischemia. , 2006, Archives of internal medicine.

[7]  P. Ridker,et al.  Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels , 2006, Circulation.

[8]  G. Lowe,et al.  Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. , 2006, American journal of epidemiology.

[9]  J. Polak,et al.  Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. , 2005, Archives of internal medicine.

[10]  G. Coppola,et al.  Critical limb ischemia: definition and natural history. , 2004, Current drug targets. Cardiovascular & haematological disorders.

[11]  A. Gamst,et al.  Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. , 2004, Journal of the American College of Cardiology.

[12]  P. Bennett,et al.  Medial arterial calcification and its association with mortality and complications of diabetes , 1988, Diabetologia.

[13]  J. Guralnik,et al.  The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study , 2002, Annals of Internal Medicine.

[14]  L. Sharma,et al.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. , 2001, JAMA.

[15]  L. Molyneaux,et al.  TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[16]  R. Langer,et al.  Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing , 1999, Vascular medicine.

[17]  A. Lee,et al.  Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.

[18]  M Suhonen,et al.  Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[19]  R. Langer,et al.  The Correlation between Symptoms and Non-Invasive Test Results in Patients Referred for Peripheral Arterial Disease Testing , 1996, Vascular medicine.

[20]  A. Smit,et al.  ROC analysis of noninvasive tests for peripheral arterial disease. , 1996, Ultrasound in medicine & biology.

[21]  K. Uekama,et al.  Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. , 1995, Clinical chemistry.

[22]  Linda P. Fried,et al.  The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability , 1995 .

[23]  B. Hedblad,et al.  Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis , 1993, The Lancet.

[24]  R. Langer,et al.  Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease , 1992 .

[25]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.